Bempedoic Acid and Cholestyramine Interaction

Drug interaction information between Bempedoic Acid and Cholestyramine.

Bempedoic Acid and Cholestyramine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Bempedoic Acid and Cholestyramine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Bempedoic Acid

ACL Inhibitor

Drug B

Cholestyramine

Bile Acid Sequestrant

How They Interact

Cholestyramine can lower the amount of the other medicine that your body is able to absorb.

FDA Label Information

Cholestyramine Clinical Impact: Concomitant use of NEXLIZET and cholestyramine decreases ezetimibe concentration. Intervention: Administer NEXLIZET either at least 2 hours before or at least 4 hours after bile acid sequestrants [see Dosage and Administration (2.2) ] .

Cholestyramine Also Interacts With

View all Cholestyramine interactions →

Frequently Asked Questions

What SPL severity band is on file for Bempedoic Acid + Cholestyramine?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Cholestyramine has 34 labeled pairs on file vs Bempedoic Acid's 7. In the minor band specifically: Bempedoic Acid has 3 (also Ezetimibe, Cyclosporine); Cholestyramine has 31 (also Propranolol, Warfarin, Tetracycline, Phenobarbital).

What mechanism field is on file for Bempedoic Acid and Cholestyramine?

Cholestyramine can lower the amount of the other medicine that your body is able to absorb.

Cholestyramine's labeled portfolio outnumbers Bempedoic Acid

SPL source-record counts only. This page's band is minor · classes on file: Bempedoic Acid (ACL Inhibitor); Cholestyramine (Bile Acid Sequestrant).

Bempedoic Acid

0 major · 4 moderate · 3 minor · 7 total

Cholestyramine

0 major · 3 moderate · 31 minor · 34 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.